Mike Auerbach

Editor-In-Chief

Mike Auerbach, Editor in Chief Email: mauerbach@comparenetworks.com | Tel.: 973-896-0362

Mike Auerbach is a seasoned professional in the field of editing and publishing, currently serving as the Editor-in-Chief at CompareNetworks. With a career spanning several decades, Auerbach has established himself as a respected figure in the pharmaceutical and life sciences publishing industry.

Auerbach's journey in editing began in 1988 when he took on the role of Editor-In-Chief at Advantage Business Media. This early experience laid the foundation for his expertise in managing editorial content and operations. In his current position at CompareNetworks, Auerbach oversees editorial content for various publications, including American Pharmaceutical Review, Pharmaceutical Outsourcing, and Tablets & Capsules magazine. He is known for his insightful articles and editorial leadership in the pharmaceutical and biotechnology sectors. Auerbach's work often focuses on cutting-edge topics such as cell and gene therapy, demonstrating his commitment to covering advancements in the pharmaceutical industry. Based in Wayne, New Jersey, Auerbach maintains an active professional presence, contributing to industry discussions and publications. His role involves not only managing editorial content but also engaging with industry professionals and staying abreast of the latest developments in pharmaceutical research and manufacturing.

Mike Auerbach

Articles by Mike Auerbach

  • About Measles, Vaccines, and Mom

    Monday, June 02, 2025
    When I was about 5 or 6, I got sick. I mean really sick. High fever, rash; the stuff of parents’ nightmares. I remember some of it – being driven to the doctor’s offi ce while lying down in the back seat of my mother’s car, ... read more
  • Chiral Separation and Enantiomeric Analysis: Critical Importance in Pharmaceutical Development

    Sunday, June 01, 2025
    Chiral separation has become a cornerstone of modern pharmaceutical development as the industry increasingly recognizes that enantiomers of chiral drugs can exhibit dramatically different biological activities, safety ... read more
  • Advances in Ionizable Lipid Design: Accelerating mRNA Therapeutic Development Through Rapid Optimization Platforms

    Sunday, June 01, 2025
    Recent breakthroughs in ionizable lipid engineering represent a paradigm shift in mRNA therapeutic development, transforming what was once a years-long optimization process into a matter of months. These advances center on ... read more
  • From TB to Today – An Evolution of Public Health

    Monday, April 14, 2025
    The human body is pretty amazing. It can heal itself, adapt to change, and provide mechanisms to rid itself of bad stuff. Of course, there are many instances when the body needs help, and medicines step in to take care of... read more
  • Collecting Facts - Tossing Out Opinions

    Tuesday, April 01, 2025
    I’m not much of a collector. For a while I was collecting 1:18 scale die-cast cars – but that kind of petered out. I also like collecting t-shirts – usually a logo from a TV show or movie, or maybe something based on my ... read more
  • When the News Hits Close to Home

    Saturday, June 01, 2024
    The three publications that I work on – American Pharmaceutical Review, Pharmaceutical Outsourcing and Tablets&Capsules all consume a lot of news. We post daily news to all three websites and feature the news in our ... read more
  • Getting Hung Up On Waste

    Monday, April 01, 2024
    My first real job after graduating college, back at the dawn of time, was as an editor for a twice-weekly newspaper that reported on current or upcoming construction projects. Our readers, who were construction contractors, ... read more
  • Pay it Forward - An Over Analyzation

    Monday, March 11, 2024
    In the simplest of definitions, to “Pay it Forward” means “respond to a person's kindness to oneself by being kind to someone else.” This can take many forms – from holding the door open for the person behind you as the ... read more
  • Is Artificial Intelligence the Next Pacer?

    Thursday, February 01, 2024
    American Motors Corporation was formed in 1954 from the merger of Nash-Kelvinator and the Hudson Motor Car Company. As an automobile manufacturer, they had some success over the years, but always trailed the Big Three – Ford,... read more
  • Inevitable AI

    Friday, December 01, 2023
    Have you ever had the feeling you were heading too fast towards something that was inevitable? read more
Page